In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price ...

CTL Aerospace Inc. in West Chester Township provided the backdrop for the latest step in Ramaswamy's meteoric rise in ...

Charleson, who appeared in over 2,000 episodes of the long-running soap opera, passed away in January at the age of 79.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the trades showed up on ...

Axsome Therapeutics (AXSM) is up more than +22% after announcing it has entered into a settlement agreement with Teva Pharmaceuticals ... Capital Group Ltd (ACGL), Cincinnati Financial Corp ...

Axsome Therapeutics shares were up 14% in premarket trading after reaching a settlement with Teva Pharmaceuticals. Shares were trading around $120.01. The stock is up 8.3% over the last year.

Looking ahead, revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Pharmaceuticals industry in the US.

39,017 people played the daily Crossword recently. Can you solve it faster than others?39,017 people played the daily Crossword recently. Can you solve it faster than others?

Teva Pharmaceutical (NYSE:TEVA) shares snapped six straight sessions of losses, as the stock closed 0.88% higher at $17.21 on Wednesday. The company lost over 20% in the preceding six sessions.